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C. elegansOrganismal growth and body size are inﬂuenced by both genetic and environmental factors. We have utilized
the strong molecular genetic techniques available in the nematode Caenorhabditis elegans to identify genetic
determinants of body size. In C. elegans, DBL-1, a member of the conserved family of secreted growth factors
known as the Transforming Growth Factor β superfamily, is known to play a major role in growth control. The
mechanisms by which other determinants of body size function, however, is less well understood. To identify
additional genes involved in body size regulation, a genetic screen for small mutants was previously
performed. One of the genes identiﬁed in that screen was sma-21. We now demonstrate that sma-21 encodes
ADT-2, a member of the ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) family of
secreted metalloproteases. ADAMTS proteins are believed to remodel the extracellular matrix and may
modulate the activity of extracellular signals. Genetic interactions suggest that ADT-2 acts in parallel with or
in multiple size regulatory pathways. We demonstrate that ADT-2 is required for normal levels of expression
of a DBL-1-responsive transcriptional reporter. We further demonstrate that adt-2 regulatory sequences drive
expression in glial-like and vulval cells, and that ADT-2 activity is required for normal cuticle collagen ﬁbril
organization. We therefore propose that ADT-2 regulates body size both by modulating TGFβ signaling
activity and by maintaining normal cuticle structure.Queens College, CUNY, 65-30
7 3445.
avage-Dunn).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Body size is a fundamental feature of an organism critical to survival
and ﬁtness, yet the mechanisms underlying its regulation remain
incompletely understood. Existing studies show that body size is in part
genetically controlled (Oldham et al., 2000). For example, in Drosophila,
the insulin/insulin-like growth factor 1 (IGF1) signaling pathway
regulates body size, so that mutants are smaller than wild-type ﬂies
(Bohni et al., 1999; Leevers et al., 1996; Neufeld and Edgar, 1998). Flies
mutant for Drosophila S6 kinase (DS6K) and d-Myc also have slow
growth, reduced cell size and small body size (Gallant et al., 1996;
Johnston et al., 1999;Montagne et al., 1999). TheDrosophila homolog of
the target of rapamycin (TOR) affects growth bymodulating the activity
of DS6K. Mutant cells are small in size (Neufeld, 2003; Oldham et al.,
2000). In contrast, the Salvador–Warts–Hippo (SWH) pathway
represses tissue size. Lack of SWH pathway component activity results
in overgrowth of adult structures (Badouel et al., 2009; Tyler and Baker,
2007; Willecke et al., 2006).In Caenorhabditis elegans, there are several known small body size
mutants. Components of the DBL-1 Transforming Growth Factor β
(TGF-β) pathway play a major role in the regulation of body size.
Mutations in any component of the pathway, dbl-1 (ligand), sma-6
(type I receptor), daf-4 (type II receptor), sma-2, sma-3, sma-4 (Smad
transcription factors) and sma-9 (transcription co-factor) result in
smaller than wild-type body size (Estevez et al., 1993; Krishna et al.,
1999; Liang et al., 2003; Savage-Dunn, 2005; Savage-Dunn et al., 2003;
Savage et al., 1996; Suzuki et al., 1999).
In addition to the DBL-1 pathway, other genes have been identiﬁed
that play less critical roles in regulation of body size. One such group is
genes that are expressed in sensory neurons, including che-2, che-3,
egl-4, tax-6 and cnb-1 (Bandyopadhyay et al., 2002; Fujiwara et al.,
2002; Kuhara et al., 2002). The che-2 and che-3mutations cause small
body size due to defects in sensory perception. egl-4 (cGMP-Dependent
ProteinKinase) acts downstreamof chemutants to regulate body size by
repressing the DBL-1 pathway (Fujiwara et al., 2002). tax-6 and cnb-1
encode the catalytic and regulatory subunits of calcineurin, respectively.
tax-6 interacts with kin-29 (ser/thr kinase) and mef-2 (MADS box
transcription factor) to regulate body size (Singaravelu et al., 2007).
Feeding defective mutants also have small body size. These include
pha-2 and pha-3with abnormal pharyngeal anatomy, eat-1, eat-2, eat-3
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pumping (Morck and Pilon, 2006). Mutations of components of the
TORC2complex result in small body size (Jones et al., 2009; Soukas et al.,
2009). Intriguing recent evidence implicates the cell deathmachinery in
the regulation of cell and body size (Chen et al., 2008). In addition,
mutations that affect the structure of the cuticle can change the body
size of the animal because the cuticle encapsulates the body. Some
examples are dpy-2, dpy-7, dpy-10, dpy-13, sqt-1, sqt-3 and lon-3. All of
these genes encode cuticular collagens (Johnstone et al., 1992; Kramer,
1994; Kramer and Johnson, 1993; Kramer et al., 1988; Levy et al., 1993;
Nystrom et al., 2002; Suzuki et al., 2002; van der Keyl et al., 1994;
von Mende et al., 1988). Finally, mutations in a small number of genes
which have yet to be assigned to a particular pathway, including sma-1
(βH-spectrin), sma-5 (MAP kinase BMK1/ERK5 homolog) and rnt-1
(RUNX family transcription factor), also cause small body size (Ji et al.,
2004; McKeown et al., 1998; Watanabe et al., 2005).
To understand the genetic basis of body size regulation, a for-
ward genetic screen for small body size mutants was carried out
(Savage-Dunn et al., 2003). In that screen, alleles of many of these
genes were identiﬁed. Furthermore, one of the novel small body size
mutants isolated was sma-21, which we now show is allelic with
ADAMTS family member adt-2.
ADAMTS (a disintegrin-like and metalloprotease with thrombos-
pondin type I motif) are secreted metalloproteases that bind to the
extracellular matrix (ECM) (Kuno and Matsushima, 1998; Porter et al.,
2005; Tang, 2001). ADAMTS are related to the ADAM (a disintegrin and
metalloprotease) subfamily of transmembrane proteins. Both ADAM
and ADAMTS proteins are Zn dependent metalloproteases (Jones and
Riley, 2005; Kaushal and Shah, 2000; Stocker et al., 1995). In mammals,
the ADAMTS proteases are believed to function in ECM assembly
(procollagen N-proteinases: ADAMTS-2, -3 and -14) and ECM degrada-
tion (aggrecanases:ADAMTS-1, -4, -5, -8, -9 and -15) (Colige et al., 1995,Fig. 1. sma-21 encodes ADT-2. (A,B,C) RNAi inactivation of adt-2 results in small body size
hypersensitive strain is used for body size measurements. (D,E,F) Fosmid WRM0636aH08
worms photographed at the same magniﬁcation. Body length was measured in adult worm
deviation. Scale bars = 0.2mm. **indicates pb0.01.1997; Collins-Racie et al., 2004; Fernandes et al., 2001; Kunoet al., 2000;
Somerville et al., 2003; Tortorella et al., 2000, 2005; Wang et al., 2003).
In C. elegans, some of these proteases are involved in organogenesis by
remodeling the ECM. For example, GON-1 and MIG-17 are involved in
distal tip cell migration in gonad development (Blelloch and Kimble,
1999; Ihara andNishiwaki, 2007).Another proteaseADT-1 is involved in
ray morphogenesis by rapid remodeling of ECM (Kuno et al., 2002).
In this study we describe the role of C. elegans ADAMTS gene adt-2
in the control of body size. Genetic interactions show that adt-2 is
likely involved inmultiple pathways that regulate body size. We show
that ADT-2 is synthesized in glial cells of sensory neurons and in the
vulva, and is required to promote DBL-1 signaling activity and for
normal cuticle structure.
Results
Isolation of sma-21 mutants
To identify genes required for body size regulation, a forward genetic
screen for small body sizemutants was carried out (Savage-Dunn et al.,
2003). In that screen, N2 hermaphrodites weremutagenized with ethyl
methanesulfonate (EMS) and the F2 progeny worms were screened for
small body phenotype. In the screen, sma-20mutantswere identiﬁed. In
the course of mapping, we found that the sma-20 strain has two
mutations, sma-20(wk31) and sma-21(wk156). Furthermore, 23 semi-
small segregantswere isolated from the doublemutant strain and itwas
found that they were all allelic to sma-21. This ﬁnding led us to the
conclusion that sma-21 regulates body size, and that sma-20 is an
enhancer of the sma-21 phenotype with no apparent phenotype on its
own. All of the analyses in this paper were performed with a sma-21
(wk156) segregant from which the sma-20 enhancer mutation was
outcrossed.. K09F5.1(RNAi) treated worms are indistinguishable from control worms. rrf-3 RNAi
containing adt-2 gene rescues the body size of sma-21(wk156). A,B,D and E are adult
s. Each value represents a mean of 30 – 60 worms. Error bars indicate the standard
Table 1
Amino acid identity of C. elegans of ADT-2 to mammalian and C. elegans ADAMTS.
Calculated using Clustalw.
Catalytic domain First TSP type 1 motif Zn binding motif
C. elegans GON-1 26 35 33
C. elegans ADT-1 41 37 36
Mouse ADAMTS-1 21 33 36
Human ADAMTS-4 25 33 54
Human ADAMTS-5 22 32 31
Human ADAMTS-2 29 37 36
Human ADAMTS-3 26 35 36
Human ADAMTS-14 25 32 36
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thrombospondin repeats) family member ADT-2
We used single nucleotide polymorphism (SNP) mapping (Davis
et al., 2005) to locate sma-21 on the X chromosome in the region
between 7,439,984 (cosmid C01C10) and 7,982,355 (cosmid F45E1).
Then, we employed array comparative genomic hybridization (aCGH)
to identify any polymorphisms in this region. An oligonucleotide chip
spanning this region was designed. This was hybridized with sma-21Fig. 2. Structure of the ADT-2 protein. (A) Domain organization of ADT-2 protein. Domain or
SignalP 3.0 Server). (B) Amino acid sequence of ADT-2. Different domains are highlighted.
Underlined is the Zn binding motif. In green is the conserved methionine residue downstream
cysteine-rich domain. Thrombospondin type I-like repeats are highlighted in blue. The loc
indicated by a shaded box and an asterisk, respectively. (C) Zinc-binding motif and Met tur
members. The conserved zinc-binding motif andmethionine residue downstream of themet
the conserved residue mutated in adt-2(wk156). (D) Phylogenetic tree showing relation
sequence Alignment Editor and MEGA 4.0.2). The numbers above the nodes indicate the peand wild-type genomic DNA at Roche NimbleGen (Maydan et al.,
2009). This analysis identiﬁed two polymorphisms in the sma-21
mutant: one in K09F5.1 and one in adt-2. Sequence analysis of PCR
fragments in sma-21 veriﬁed the two SNPs: one at 7,590,038 bp (G to
A) in the adt-2 gene and the other at 7,740,620 (G to A) in K09F5.1. To
determine which of these mutations is responsible for the small body
size phenotype in sma-21, we used RNAi and transformation rescue.
We inactivated the corresponding genes by feedingN2 (wild type) and
rrf-3 (RNAi hypersensitive) worms on adt-2 RNAi and K09F5.1 RNAi
plates (Kamath et al., 2001). adt-2RNAi fedworms are small unlike the
K09F5.1 RNAi (Fig. 1). Then, we introduced fosmid clones containing
adt-2 wild-type sequences into sma-21 mutants by microinjection
(Mello et al., 1991). The fosmid clone WRM0636aH08 which contains
the full-length adt-2 wild-type gene rescues the body size of sma-21
(wk156) (Fig. 1). Finally, we performed a complementation test
between sma-21 and a deletion allele of adt-2(tm975) obtained from
the CGC. The complementation test shows that these two mutations
fail to complement for body size. Putting all the data together, we can
conclude that sma-21 encodes adt-2. Wewill therefore refer to sma-21
as adt-2.
In order to verify the exon–intron structure of adt-2,we sequenced
cDNA clones obtained from Dr Yuji Kohara. Sequencing of multiple
cDNA clones gave no evidence for alternative splicing. The sequence ofganization of mammalian ADAMTS-2 is shown for comparison (predicted by SBASE and
In red is the signal sequence; in violet, the prodomain; in brown, the catalytic domain.
of the metal binding motif which forms ‘Met turn’ (Porter et al., 2005). In yellow is the
ation of the deletion in tm975 and the missense mutation (Gly364-Ser) in wk156 are
n of C. elegans ADT-2 are aligned with other mammalian and C. elegans ADAMTS family
al binding site are shaded. Asterisks indicate conserved amino acids. The glycine in red is
ships between C. elegans and human ADAMTS sequences (constructed using BioEdit
rcent bootstrap values in 500 replicates of the data.
Fig. 3. Phenotypes of adt-2 mutants. (A) adt-2(wk156) mutant has small body size. Growth curve of adt-2 showing reduced growth rate compared to wild-type N2 worms. Each time point represents a mean of 25–50 animals. Error bars
indicate the standard deviation. Body size of adt-2mutant at each point except 24 h is signiﬁcantly different from that of wild-type. (B,C) Lethal phenotype of adt-2(tm975) deletion homozygotes. Images show an unhatched embryo (three-
fold stage; B) and a partially hatched larva (C). D) Reduced lifespan of adt-2mutants. A Kaplan–Meier survival curve shows the lifespan of wild-type N2 (blue; median survival 16 days), mutant adt-2(wk156) (brown; median survival 10 days;
logrank statistical comparison pb0.0001 relative to N2), adt-2(RNAi) (orange; median survival 8 days; logrank statistical comparison pb0.0001 relative to N2) and adt-2(RNAi) initiated in adulthood (green; median survival 14 days; logrank
statistical comparison pb0.0001 relative to N2). For each strain, n=120 worms.
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consists of 20 exons (exon 1 is non-coding) that encode a protein of
1020 amino acids. ADT-2 belongs to the ADAMTS family of secreted
extracellular metalloproteases. These proteins bind to extracellular
matrix (ECM) and are believed to be involved in remodeling of the
ECM (Porter et al., 2005). As shown in Table 1, the catalytic domain of
ADT-2 shows 21% to 41% homology to other ADAMTS family
members. These proteins are comprised of several domains. Starting
with the N terminus, ADT-2 has a signal peptide (predicted by SignalP
3.0 Server); a catalytic domain with a reprolysin- type zinc-binding
motif, HEX1X2HX3X1GX1XHD [where X1 is typically hydrophobic aa,
X2 is glycine or a hydrophobic aa and X3 is asparagine (http://www.
lerner.ccf.org/bme/apte/adamts/domain_organization.php)]; a cysteine-
rich domain; a central TS (thrombospondin type I-like) domain and six
C-terminal TS repeats (predicted by SBASE release 14, Sept 2006)
(Fig. 2A). The domain organization of mammalian ADAMTS-2 is shown
for comparison (Fig. 2A). Table 1 shows the amino acid identity in the
zinc-binding motif, catalytic domain and in the ﬁrst thrombospondin
type I-like repeat of C. elegans ADT-2 compared to mammalian and
C. elegans ADAMTS. The metalloprotease domain of ADT-2 shows the
highest similarity to ADAMTS-2, -3, and -14 among mammalian
ADAMTS family members (Table 1 and Fig. 2D).
adt-2(wk156) is a missense mutation that changes a conserved
glycine residue to a serine (highlighted in red in Fig. 2C) within the
metal bindingmotif. Conservation of this glycine residue suggests that
it is functionally important. adt-2(tm975) has a deletion of 475 bp
(WormBase; Fig. 2B)which deletes 92 amino acidswithin the catalytic
domain including the metal binding motif. adt-2(tm975) is lethal.
Homozygous adt-2(tm975) mutants die at the 3-fold stage of embryo-
genesis or during hatching (Figs. 3B and C).
Phenotypic characterization of adt-2
To characterize the body size phenotype of adt-2(wk156), we
created growth curves that indicate the body length of wild-type N2
worms and adt-2(wk156) worms at various times after egg collection
(Fig. 3A). Newly hatched adt-2 mutant larvae have the same body
length as control animals, similar to dbl-1 pathway mutants. adt-2
mutant worms grow more slowly after 24 hours resulting in adult
worms with about a 20% reduced body length when compared to wild
type. Interestingly, adult adt-2 mutants show a signiﬁcant decrease in
body length between 96 and 120 h, whereas wild-type animals con-
tinue to grow larger during adulthood. The reduction in body length
in adt-2 mutants suggests that the gene is required for maintenance
of body length as well as for increase in body length during growth
stages.
We have also examined the body width of adt-2 mutants. Typical
small mutants, such as those defective in the DBL-1 pathway, have
reduced width as well as reduced length. In contrast, dumpy mutants,
such as those defective in some cuticle collagens, have reduced lengthTable 2
Cell and nuclei measurements of adt-2 and wild-type worms.
N2 adt
Seam cell number 16+/−0 16+
(Adult) (n=30) (n=
Intestinal nuclei number 31.4+/−1.2 31.5
(Adult) (n=31) (n=
Hypodermal nuclei number 116.3+/−11.9 114
(L4) (n=33) (n=
Seam cell perimeter (mm) 0.073+/−0.011 0.06
(L3) (n=78) (n =
Pharynx length (mm) 0.109+/−0.006 0.10
(L3) (n=18) (n=
Body size (mm) 0.651+/−0.053 0.57
(L3) (n=23) (n=
**pb0.01 compared to control.but not reduced width. adt-2(wk156) mutants show a signiﬁcantly
increased body width, 0.072 mm+/−0.005 mm vs 0.066 mm+/
−0.005 mm for N2 wild-type controls grown concurrently under the
same conditions, pb0.01 (see also Fig. 1E). In contrast, adt-2(RNAi)
animals show a signiﬁcantly reduced body width, 0.072 mm+/
−0.006 mm vs 0.089 mm+/−0.006 mm for control animals grown
concurrently under the same conditions, pb0.01 (see also Fig. 1B). Thus,
the partial loss-of-function adt-2(wk156) mutant resembles a dumpy
mutant, whereas more severe loss-of-function due to RNAi inactivation
results in a more characteristic small phenotype.
We next evaluated the effects of adt-2 on lifespan. Both adt-2
(wk156) and adt-2(RNAi) have signiﬁcantly reduced lifespans com-
pared to wild type, with a median survival of 10 and 8 days from
adulthood, respectively, compared with 16 days for wild type
(Fig. 3D). Since early lethality could be due to developmental defects
associated with adt-2 loss-of-function, we also measured lifespan of
animals grown under normal conditions until adulthood and then
transferred to adt-2(RNAi) conditions. These animals also show
reduced adult longevity, with a median survival of 14 days and a
maximum survival reduced from 21 days to 18 days (Fig. 3D). Overall,
the median lifespan of adt-2 mutants and adt-2(RNAi) under
conditions tested is reduced by 13% to 50% relative to wild type.
Thus, adt-2 activity is required to promote normal adult longevity.
The reduction in body length of adt-2 mutants could be due to
decreased cell number, cell size or alterations in cellular or extra-
cellular morphology. In order to determine which cause is responsible
in this case, weﬁrst examined the number of seam cells, the number of
intestinal cells, and the number of hypodermal nuclei in wild-type and
adt-2mutant animals. The number of seam cells was measured using
the seam cell marker::GFP reporter, and found to be not signiﬁcantly
different in adt-2(wk156) or adt-2(RNAi) compared to controls
(Table 2). DAPI staining was done in order to count intestinal nuclei,
which are the same in adt-2(wk156) and adt-2(RNAi) compared with
controls (Table 2). We also counted the number of nuclei in the
hypodermis of fourth larval stage (L4) worms of adt-2(wk156), adt-2
(RNAi), and control animals. Hypodermal nuclei were counted using
the dpy-7p::2Xnls::yfpmarker, which is expressed in hypodermal cells
beginning at the L1 stage (Myers and Greenwald, 2005). The number
of hypodermal nuclei is not signiﬁcantly different in adt-2 mutants
compared to control animals (Table 2). For comparison, we deter-
mined the number of hypodermal nuclei in dbl-1 mutants, which is
also not signiﬁcantly different from wild type (114.6+/−9.4). These
results are consistent with previous reports that DBL-1 pathway
mutants have normal numbers of hypodermal nuclei (Nagamatsu and
Ohshima, 2004).
We also measured the dimensions of two accessible tissues (seam
cells and the pharynx) in adt-2 and wild type. We crossed an ajm-1::
gfp seam cell marker into adt-2(wk156) or fed the strain adt-2(RNAi)
bacteria and observed ﬂuorescence in the L3 larval stage. The ajm-1::
gfp marker localizes at the adherens junctions in the seam cells-2(wk156) RNAi control adt-2(RNAi)
/−0 16.1+/−0.7 16.2+/−0.4
30) (n=10) (n=20)
+/−1.4 32.7+/−1.4 33.4+/−1.0
38) (n=10) (n=20)
.1+/−10.7 145.4+/−6.3 145.9+/−4.0
31) (n=5) (n=10)
7**+/−0.011
76)
8+/−0.009
18)
5**+/−0.065
27)
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L3 worms were also measured. The length measurements for adt-2
(RNAi) animals are not signiﬁcantly different from controls at the L3
stage (data not shown). The perimeters of individual seam cells and
the overall body length of adt-2(wk156), however, are reduced
signiﬁcantly compared to wild-type animals, while the length of the
pharynx is not affected (Table 2). These data are consistent with the
hypothesis that adt-2 mutants are smaller at least partly due to
decreased cell size or altered cell morphology, rather than decreased
cell number. Our previous analysis of DBL-1 pathway mutants
similarly revealed size reductions in the seam cells but not in the
pharynx (Wang et al., 2002). Thus, the adt-2 size defects are similar to
those seen in mutants of the DBL-1 signaling pathway.
Genetic interactions of adt-2 and other body size mutants in C. elegans
The DBL-1 pathway plays a major role in body size regulation in
C. elegans. Mutations in any components of the pathway, dbl-1
(ligand), sma-6 (type I receptor), daf-4 (type II receptor), sma-2, sma-Fig. 4. Genetic interactions of adt-2 and other small body size mutants in C. elegans. In each
indicated single mutant and corresponding double mutant with adt-2(wk156) or adt-2(RNAi
of more than 27 adult animals measured at 96 h after embryo collection (except daf-4 an
deviation. ** indicates pb0.01 for the pairwise comparison between the single mutant and3, sma-4 (Smad transcription factors), sma-9 (transcription co-factor)
will result in smaller bodies than wild type (Estevez et al., 1993;
Krishna et al., 1999; Liang et al., 2003; Savage-Dunn, 2005; Savage-
Dunn et al., 2003; Savage et al., 1996; Suzuki et al., 1999). Double
mutants were created in order to determine the relationship between
adt-2 and dbl-1 pathway components. The dbl-1 pathway mutants we
used for this are null or strong alleles. Double mutants of adt-2
(wk156) combined with dbl-1(wk70), sma-6(wk7), daf-4(e1364),
sma-2(e502), sma-3(wk30), sma-4(e729) or sma-9(wk55) have a
smaller body size than the respective single mutants (Fig. 4A),
indicating that adt-2 may act in a parallel pathway to regulate body
size. To further validate this result, we looked at the dbl-1 over-
expression [dbl-1(++)] phenotype in the adt-2 mutant background.
dbl-1(++) results in a long (Lon) body phenotype in an otherwise
wild-type background, but the small (Sma) phenotypes of sma-2,
sma-3, sma-4, sma-6 and daf-4 are epistatic to the Lon phenotype of
dbl-1(++). This epistasis places the activity of these sma genes
downstream of the DBL-1 ligand activity (Suzuki et al., 1999). We fed
dbl-1(++) worms on adt-2 RNAi plates. However, rather than thegraph ﬁrst two bars represents N2 and adt-2(wk156). Subsequent bars represent the
). Data are shown as a percentage of wild-type body length. Each bar represents a mean
d daf-4;adt-2 which were grown at 15°C for 144 h) . Error bars indicate the standard
the corresponding double mutant with adt-2.
Table 3
Epistasis analysis between adt-2 and dbl-1 overexpression.
Genotype Body length in adult animals n
N2 1.193+/−0.065 33
adt-2 1.004+/−0.048 28
ctIs40[pTG96(sur-5::gfp); dbl-1(++)] 1.336+/−0.069 33
adt-2; ctIs40[pTG96(sur-5::gfp);dbl-1(++)]a,b 1.177+/−0.07 33
a Value is not signiﬁcantly different from N2, pN0.05.
b Value is signiﬁcantly different from both adt-2 and ctIs40, pb0.0001.
98 T. Fernando et al. / Developmental Biology 352 (2011) 92–103expected Sma phenotype, if the adt-2 gene activity were downstream,
the body length is intermediate (Table 3). This is evidence that adt-2
acts at least partially independently of the DBL-1 pathway.
To determine whether adt-2 interacts with other pathways that
regulate body size, we next testedmutants in sensory processing. che-
2 and che-3mutants have impaired sensory cilia and therefore defects
in sensory perception. They also have a small body size phenotype.
EGL-4 cGMP-dependent protein kinase acts downstream of che genes
to regulate body size by repressing the dbl-1 pathway (Fujiwara et al.,
2002). The tax-6 and cnb-1 genes encode calcineurin A and B subunits.
Both tax-6 and cnb-1 are expressed in sensory neurons. Mutations in
these genes cause pleiotropic defects including small body size andFig. 5. Expression of RAD–SMAD, a DBL-1 pathway transcriptional reporter. GFP expressionwa
(RNAi)bacteria; (C, D) lon-2mutant fed control or adt-2(RNAi) bacteria; (E, F) dbl-1mutant fed c
and the mean length shown in mm in each panel. In each case, the adt-2(RNAi) treatment reddefects in sensory neuronal behavior (Bandyopadhyay et al., 2002;
Kuhara et al., 2002). cnb-1 also has a transparent appearance because
of thinning of the cuticle (Bandyopadhyay et al., 2002). In order to see
whether adt-2 functions in the chemosensory pathways, double
knockdowns between adt-2 and egl-4, che-2, tax-6, and cnb-1 were
made by combining existing chromosomal mutations and RNAi
inactivation of adt-2. Alleles chosen were likely molecular nulls
or the characterized reference alleles for each gene. The egl-4(n477);
adt-2(RNAi) double knockdowns have an intermediate body size
compared to egl-4 and adt-2 single mutant animals. The che-2(e1033);
adt-2(RNAi), tax-6(ok2065);adt-2(RNAi), and cnb-1(p675);adt-2
(RNAi) double knockdowns also show additive effects (Fig. 4B). The
feeding defective mutants pha-2 and pha-3 (Morck and Pilon, 2006)
were also analyzed, and found to have additive effects on body sizewith
adt-2 (Fig. 4B). A deletion allele of pha-2 is lethal, precluding the
possibility of testing for body size phenotypes in the pha-2 homozygous
mutant background.
To test whether adt-2 functions in the same pathways as rnt-1 and
sma-1, rnt-1(ok351);adt-2(wk156) and sma-1(e30);adt-2(wk156) dou-
ble mutants were constructed, using a deletion allele of rnt-1 and a
nonsense allele of sma-1. The rnt-1 gene is the C. elegans homologue of
mammalian RUNX transcription factors (Ji et al., 2004). sma-1 encodess assessed at the L2 stage in hypodermal nuclei. (A, B)Wild-type strain fed control or adt-2
ontrol or adt-2(RNAi)bacteria. Body lengthof the same strainswasmeasured in adulthood,
uced body size compared to the respective control strain signiﬁcantly (pb0.01).
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a small body size phenotype. Double mutants of rnt-1(ok351);adt-2
(wk156) and sma-1(e30);adt-2(wk156) show additive effects
(Fig. 4C). Thus, we can conclude that adt-2 acts independently of all
tested pathways, or is involved in multiple pathways that regulate
body size.
Since adt-2may act in multiple pathways to regulate body size, we
tested whether it has an effect on a DBL-1 pathway transcriptional
reporter. The RAD–SMAD reporter (a generous gift of Jun Liu) consists
of tandem Smad GTCT binding sites driving expression of nuclearly
localized GFP (Tian et al., 2010). GFP expression levels from this
construct are positively regulated by DBL-1 signaling (Tian et al., 2010)
(Figs. 5A, C, E). We tested whether RAD–SMAD expression is regulated
by adt-2(RNAi). adt-2(RNAi) reduces the expression of RAD–SMAD in an
otherwise wild-type background (Figs. 5A and B). LON-2 is a glypican
that negatively regulates DBL-1 activity (Gumienny et al., 2007). In the
lon-2 mutant background, RAD–SMAD expression is increased (Tian
et al., 2010) (Fig. 5C), and this expression is also reduced by adt-2(RNAi)
(Fig. 5D). In the dbl-1 mutant background, RAD–SMAD expression is
reduced to a few dimly ﬂuorescing nuclei in the posterior (Fig. 5E) and
this expression is not diminished further by adt-2(RNAi) (Fig. 5F). Thus,
adt-2 is a positive regulator of a DBL-1-responsive reporter. Further-
more, unlike the additive effect on body size regulation, the effects of
dbl-1 and adt-2 on RAD–SMAD regulation are not additive, indicating
that ADT-2 regulates this reporter via the DBL-1 pathway.We therefore
conclude that ADT-2 directly or indirectly regulates DBL-1 signaling
activity.
adt-2 may regulate body size in part by modiﬁcation of the external
cuticle
Our results thus far indicate that ADT-2 may regulate body size in
part by modulation of DBL-1 signaling activity, but also in part
independently of the DBL-1 pathway. Since ADAMTSs are known to
process ECM proteins, we considered whether adt-2 might regulate
body size by targeting the cuticle. The cuticle of C. elegans is a collagen-
containing extracellular matrix that surrounds the body and lines the
fourmajor openings to the exterior (pharynx, excretory pore, vulva, and
anus). The cuticle is known to play a role in determining body size and
morphology. In particular, the genes dpy-2, dpy-7, dpy-10, dpy-13, sqt-1,
sqt-3 and lon-3 that encode cuticular collagens are required for normalFig. 6. Expression patternof an adt-2 reporter construct adt-2p::gfp. adt-2 is expressed in the glialbody length (Johnstone et al., 1992; Kramer, 1994; Kramer and Johnson,
1993; Kramer et al., 1988; Levy et al., 1993; Nystrom et al., 2002; Suzuki
et al., 2002; vanderKeyl et al., 1994; vonMende et al., 1988). Inaddition,
the adt-2(wk156) mutant phenotype is similar to the dumpy pheno-
types displayed by some of these mutants. To test the hypothesis that
adt-2 functions via the cuticle,weﬁrst determined thegene's expression
pattern using a transcriptional fusion of GFP to putative adt-2 promoter
sequences. No expression from the transgene is seen in embryonic
stages. It is possible that adt-2 is maternally provided for embryonic
development, but that adt-2p::gfp expression is silenced in thematernal
germline. GFP expression is detected in glial cells associated with
amphid, phasmid, labial and posterior deirids (PDE) sensory neurons as
early as the L1 stage and continuing throughout larval development
(Figs. 6A–C). Expression is also seen in vulval tissue in L4 and adult
animals (Fig. 6D). We note that these glial and vulval cells are in close
association with the external cuticle, so it is possible that ADT-2 exerts
its inﬂuences by proteolytic processing of cuticle proteins such as
collagen. It is also possible that adt-2 is expressed in additional locations,
if this construct does not contain all of the sequences necessary for
normal expression of adt-2.
To determinewhether ADT-2 is secreted to the cuticle, we examined
the localization of an ADT-2::GFP fusion protein. We used fosmid
recombineering (Tursun et al., 2009) to insert GFP coding sequences at
the C-terminal end of the adt-2 coding sequence. Mixtures of
recombineered fosmids were injected into adt-2(wk156) animals,
yielding a total of nine independent transgenic lines. Six of nine lines
rescue the small body size phenotype of adt-2(wk156), indicating that
the GFP fusion is functional. Nonetheless, no consistent green
ﬂuorescence above background levels is seen in these lines (data not
shown). The lack of GFP could indicate that ADT-2 protein does not
accumulate to a high level, or that the C-terminus is proteolytically
processed and degraded.
To test whether ADT-2 acts to regulate cuticle collagen organiza-
tion, we used a COL-19::GFP protein fusion (Thein et al., 2003) to
visualize the cuticle collagen ﬁbrils in adt-2mutant and RNAi animals.
This reporter construct is expressed in annuli and lateral alae of the
adult cuticle [(Thein et al., 2003); Fig. 7A]. In adt-2(wk156) mutants,
which have the least severe body size phenotype, no signiﬁcant
disruption of the COL-19::GFP organization is observed. In these
mutants, the annuli are constricted (Table 4), which could be either a
primary or secondary defect, but is also seen in some collagenmutantscells of amphid and labial neurons(A), phasmids (B), andpostdeirid (C) and in thevulva (D).
Fig. 7. Aberrant COL-19::GFP localization in adt-2mutants. (A,C,E) COL-19::GFP expression. (B,D,F) Nomarski microscopy image of cuticular alae. In wild-type animals, COL-19::GFP
fusion protein is expressed in annuli extending over most of the dorsal and ventral cuticle (A). The cuticle of adult wild-type hermaphrodite shows lateral alae with three
characteristic ridges (B). RNAi inactivation of adt-2 causes an expanded region of disruption in the lateral cuticle (double headed arrow; C). Patches of disorganization of the annuli
are also evident in the adt-2(tm975/wk156) adult worms (E). Nomarski microscopy images of the cuticle of adt-2(tm975/wk156) hermaphrodites show abnormal numbers of alae
(arrowheads; four in D and two in F), as well as discontinuous alae (D; arrows from ﬁrst asterisk mark region in which third ridge from top is discontinued; second asterisk marks
region in which top ridge is discontinued, transitioning from four alae to three alae).
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(RNAi) show signiﬁcant disruptions of the lateral cuticle overlying the
seam cells. We also detect constrictions of the annuli in adt-2(RNAi)
worms (Fig. 7C and Table 4). We analyzed COL-19::GFP localization in
adt-2(tm975/wk156) transheterozygous animals, revealing patches of
disorganized annuli (Fig. 7E) and structural defects in the alae. The
defects are discontinuous alae and alae with two or four ridges as
compared to three ridges in the wild-type worms (Figs. 7B, D and F).
These disruptions may partially explain the reduced body size in adt-2
mutants and knockdowns.
Discussion
sma-21, a gene required for normal body size in C. elegans, encodes ADT-2
ADAMTS secreted metalloprotease
To characterize thegenetic regulation of body size,weundertook the
molecular cloning of sma-21, a gene required for normal larval and adult
body size in the nematode C. elegans. Four independent pieces of
evidence demonstrate that sma-21 encodes ADT-2. First, sma-21
mutants contain a missense mutation in a conserved glycine residue
in the catalytic domain of ADT-2. Second, inactivation of ADT-2 by RNAi
phenocopies the small body size defect of sma-21 mutants. Third,
genomic clones containing adt-2 are sufﬁcient to rescue the body size
defect of sma-21mutants. Fourth, a lethal deletion allele of adt-2 fails to
complement sma-21(wk156) for the body size defect.
adt-2 mutants and knockdowns display a graded series of defects.
The originalwk156mutation likely results in a partial loss-of-function,
since it causes a mild body size phenotype that is enhanced in trans
with a deletion allele. Thewk156mutational lesion results in an amino
acid substitution for a conserved glycine residue in the zinc-bindingTable 4
adt-2(wk156) and adt-2(RNAi) worms have constricted annuli.
Genotype RNAi treatment Distance
kaIs12[COL-19::GFP] None 1.809+
kaIs12[COL-19::GFP];adt-2(wk156) None 1.478+
kaIs12[COL-19::GFP] Empty vector control 1.656+
kaIs12[COL-19::GFP] adt-2(RNAi) 1.437+
**pb0.01.motif of the catalytic domain. The resultingmutant protein apparently
retains partial activity. Knockdown of adt-2 by RNAi causes a more
severe body size phenotype than in thewk156mutant, as well as some
lethality. Finally, the deletion allele tm975, which removes a large part
of the catalytic domain including the metal binding motif, causes late
embryonic lethality.
The molecular identiﬁcation of SMA-21/ADT-2 demonstrates a role
for ADAMTS function in the regulation of body size in C. elegans. This
function inbody size regulationmaybea conserved activity forADAMTS
proteins. Consistent with this model, ADAMTS mutations and variants
are associatedwith normal andpathological variations in humanheight.
For example, ADAMTS2 is associated with connective tissue disorders
such as EDS (Ehlers–Danlos syndrome) in humans and with dermatos-
paraxis in cattle. Both disorders are characterized by fragility of skin and
short stature (Colige et al., 1999; Lenaers et al., 1971). A mutation in
ADAMTS10 is associated with Weill–Marchesani syndrome (WMS), a
disorder that is characterized by the short body size, short ﬁngers and
toes, joint stiffness and eye anomalies (Dagoneau et al., 2004). In
addition, amutation inADAMTSL2 (ADAMTS-like2) leads to geleophysic
dysplasia, a condition characterized by short stature and digit
abnormalities (Le Goff et al., 2008). Finally, gene variants in human
ADAMTS10, ADAMTS17 and ADAMTSL3 (ADAMTS-like3) are associated
with variation in human height (Gudbjartsson et al., 2008; Lettre et al.,
2008; Weedon et al., 2008).
ADT-2 is required for normal cuticle collagen ﬁbril structure and DBL-1
signaling activity
In mammals, ADAMTS proteases can be divided into two classes:
those involved in ECM assembly (procollagen N-proteinases:
ADAMTS-2, -3 and -14) and those involved in ECM degradationbetween annuli (μm) Number of annuli Number of worms
/−0.18 390 15
/−0.14** 688 20
/−0.20 459 17
/−0.16** 690 21
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members of the ADAMTS family present in C. elegans. Two of these,
GON-1 and MIG-17, are more similar to the aggrecanases involved in
ECM degradation. These two proteins are involved in cell migrations
during organogenesis, and may function by locally degrading the
basement membrane ECM. In contrast, ADT-1 and ADT-2 are more
similar to the collagenases that are required for ECM assembly. ADT-1
is required for themorphogenesis ofmale copulatory organs, a process
that requires rapid remodeling of the ECM.
In C. elegans one ECM tissue, the cuticle, plays a major role in
determining body size due to the fact that it encapsulates C. elegans.
adt-2 mutants show a series of defects in the cuticle. We have
observed the COL-19::GFP collagen fusion protein marker in adt-2
mutant and RNAi backgrounds, and found that the recruitment of this
collagen fusion protein into ﬁbrils in the cuticle is aberrant. We see
major disruptions of the COL-19-containing ﬁbrils, particularly in the
lateral cuticle underlying the alae. These defects are associated with
shorter distances between the rings of annuli indicating excessive
longitudinal constriction of the cuticle. Defects in the alae can also be
seen by Nomarski DIC microscopy, including the presence of two or
four lateral ridges instead of the normal three, and the presence of
short discontinuities in the alae ridges. These defects are reminiscent
of defects reported in a subset of cuticle collagen mutants such as
dpy-5, dpy-13, and bli-1, and in col-19(RNAi) animals. Interestingly,
adt-2 was also previously identiﬁed in an RNAi screen for genes
required for molting of the cuticle (Craig et al., 2007; Frand et al.,
2005). Taken together, these results are consistent with a focus of
action for ADT-2 in the cuticle. Due to the defects in the cuticle of adt-2
mutants, the cuticle may not be able to maintain its integrity, which
leads to the resultant defect in body size. Also, adt-2(wk156)mutants
lose length rather than growing during adulthood, which could be
caused by a lack of cuticle integrity. These defects in the cuticle can
also explain the reduced lifespan of adt-2 mutants as an increased
vulnerability to injuries and infection.
To test for an inﬂuence of ADT-2 on the DBL-1/BMP signaling
pathway, themajor size regulating pathway in C. elegans, we employed
a DBL-1-responsive transcriptional reporter, RAD–SMAD (Tian et al.,
2010). Intriguingly, adt-2 inactivation leads to a reduction in expression
of this reporter, indicating that ADT-2 also regulates body size in part by
direct or indirect modulation of DBL-1 signaling. Since TGFβ ligands are
often secreted in inactive forms that must be activated by proteolysis
(Lawrence, 2001), it possible that ADT-2 is directly involved in
activation of DBL-1. Based on the other roles of ADT-2 in the cuticle,
however, we ﬁnd it more likely that ADT-2 plays an indirect role.
Consistent with this hypothesis, ECM is known to inﬂuence the activity
of signaling pathways; for example, ECM collagens act as regulators
of BMP signaling in Drosophila (Wang et al., 2008). It is therefore
possible that ADT-2 modiﬁcation of the ECM leads to changes in DBL-1
bioavailability.
Materials and methods
Strains
C. elegans strains were grown at 20 °C using standard methods
(Brenner, 1974), except for daf-4, which was grown at 15 °C to
prevent constitutive Dauer formation. All of the analyses reported
here were performed with a sma-21(wk156) segregant from which
the sma-20 enhancer mutation was outcrossed. In addition to strains
generated in this study the following strains were used:
N2 and HA (wild type)
LG I: rnt-1(ok351)
LG II: cnb-1(ok276)
LG III: sma-2(e502), sma-3(wk30), sma-4(e729), daf-4(e1364)
LG IV: tax-6(ok2065), egl-4(n477), pha-3(ad607)LG V: dbl-1(wk70), sma-1(e30), him-5(e1490)
LG X: adt-2(tm975) obtained from Dr. Shohei Mitani, National
Bioresource Project for the nematode, Tokyo Women's Medical
University School of Medicine, Japan; sma-9(wk55), che-2(e1033),
pha-2(ad472).
Transgenics: dbl-1(ctIs40) (Suzuki et al., 1999); TP12 [COL-19::GFP]
obtained from Dr. Antony Page; wIs51 [SCM::GFP, unc-119(+)]; jcIs1
[ajm-1::gfp] obtained from Dr. Jeff Simske; arIs99 [dpy-7p::2Xnls::yfp]
obtained fromDr. Iva Greenwald; jjIs2277[RAD–SMAD+mec-7p::rfp],
lon-2(e678);jjIs2277, and sma-6(wk7);jjIs2277 (Tian et al., 2010)
obtained from Dr. Jun Liu.
Mapping and cloning of sma-21
We used SNP mapping (Davis et al., 2005) and aCGH (Maydan
et al., 2009) as previously described. Brieﬂy, a microarray was
designed for a 0.6 MB region delimited by the standard SNP mapping
protocol using an application at http://hokkaido.bcgsc.ca/SNPdetection/.
Processing of themicroarraywas done byRoche/NimbleGen. To conﬁrm
the polymorphisms identiﬁed by aCGH, we generated PCR fragments
ﬂanking the mutation sites and directly sequenced them. Primer
sequences are available on request. The PCR ampliﬁcation produces
752 bp fragment for the wild-type allele and a 277 bp fragment for
the deletion allele. For rescue, 10 ng/μl fosmid DNAwas injected into the
gonadal syncytia of sma-21(wk156) hermaphrodites with myo-3::
mcherry (kindly provided by Dr. Hannes Bülow) as a marker (Mello
et al., 1991). Total concentration of the DNA at injection was adjusted to
100 ng/μg using Bluescript SK. yk cDNAs spanning this region were
obtained from Dr. Y. Kohara. The yk1586e04 was sequenced and the
predicted transcript structure was veriﬁed. Primers used for sequencing
the yk clone are available upon request.Measurement of nuclear and cell numbers
We counted the number of nuclei in the hypodermis, seam cells
and intestine in wild-type and adt-2 mutant animals. DAPI staining
was used to label the intestinal nuclei. N2, adt-2 worms were ﬁxed
with acetone, washed with PMB (50 mM Na2HPO4 pH 7.5, 1 mM
MgCl2) and immersed in 500 μl/ml DAPI solution for 30 min. Worms
were then washed twice with PMB and the intestinal nuclei were
counted. The number of seam cell nuclei was counted using the
transgene wIs51 [SCM::GFP, unc-119(+)], a seam cell marker in adult
animals (Clucas et al., 2002). The number of nuclei in the hypodermis of
L4 animals was counted using the transgene arIs99 [dpy-7p::2Xnls::yfp],
a hypodermal reporter, which is expressed in hyp7 and other
hypodermal cells (Myers and Greenwald, 2005). Individual seam cell
perimeters were measured in L3 larvae using the ajm-1::gfp marker
(Mohler et al., 1998)which localizes to adherens junctions. The lengthof
the pharynx and the body size of the same L3 worms were also
measured. These markers were introduced into adt-2(wk156) by
standard genetic crosses. Images were taken using a confocal or
epiﬂuorescence microscope.RNAi feeding
RNAi feeding was performed as described in Kamath et al. (2001).
Six L4 animals were transferred to feeding plates, incubated
overnight, transferred to fresh plates and the progeny were scored.adt-2 expression
We used PCR fusion based approach to create adt-2p::gfp construct
(Hobert, 2002). We ampliﬁed 4492 bp region of genomic DNA
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reporter. Primers used for fusion were:
adt-2A: 5′ GC GGA TCC TAA AAC TAT AGG AAA TTC GGA 3′
adt-2A*: 5′ GC GGA TCC TTT ATG TAA TAC TAA TAC TGG 3′
adt-2B: 5′ GAA AAG TTC TTC TCC TTT ACT CAT aat gtt gtt ctg gag ttg
gca gaa 3′
adt-2B*: 5′ GAAAAG TTC TTC TCC TTT AC TCA Ttg aga ata tgc aga ttt
cac aac g 3′
20 ng/μl adt-2p::gfp construct was microinjected to N2 hermaph-
rodites along with myo-3::mcherry as a transformation marker. Total
concentration of the DNA at injection was adjusted to 100 ng/μl using
Bluescript SK.
Analysis of body size measurements
To characterize the body size phenotype of adt-2, we created
growth curves by measuring the body lengths of wild-type N2 worms
and adt-2(wk156) at various times after embryo collection. Worms
were grown at 20°C and photographed using Axio Vision 3.00
software. The length of each worm was determined by drawing a
segmented line along the midline using the same software. To analyze
body width, adt-2(wk156) and adt-2(RNAi) adult worms were
photographed at 96 h after embryo collection and the width
measured at a position through the vulva in the center of the body.
For body length measurements of the single and double mutants,
96 h old worms (144 h for daf-4 and daf-4;adt-2 doublemutant grown
at 15°C) were photographed using QC Capture 2.73.0 and the length
was measured using Image-Pro Express 5.1.0.12 software.
Lifespan assay
Synchronous animals were obtained by bleaching of gravid
hermaphrodites. 120 L4 worms from wild type, adt-2(wk156) and
adt-2(RNAi) were picked. Adult N2 worms also treated with adt-2
RNAi were tested for their lifespan. From each strain, the L4 worms
were divided into 12 plates with 10 worms per plate. Worms were
transferred to fresh plates every other day and the number of
surviving worms was counted. Worms were marked as dead if they
failed to respond to the nose tap with a platinum wire. Kaplan–Meier
survival analysis was used to compare themedian lifespan of different
strains of animals.
Generation of double mutants
Double mutants containing mutations in the sma-6, daf-4, sma-2,
sma-3, sma-4, sma-9, sma-1 and rnt-1 genes were created by crossing
adt-2(wk156);him-5(e1490) males into the hermaphrodites of each
mutant and scoring progeny for the expected phenotypes. The rnt-1
(ok351) deletion mutation was conﬁrmed by PCR. All the other
mutations were conﬁrmed by complementation tests. che-2(e1033);
adt-2(RNAi), egl-4(n477);adt-2(RNAi), tax-6(ok2065);adt-2(RNAi),
cnb-1(ok276);adt-2(RNAi), pha-2(ad472);adt-2(RNAi), and pha-3
(ad607);adt-2(RNAi) double knockdowns were made by feeding
che-2, egl-4, tax-6, cnb-1, pha-2, and pha-3 mutant worms with adt-2
dsRNA expressing bacteria.
COL-19::GFP localization in adt-2(wk156)
In order to see the cuticle of adt-2(wk156), an adult speciﬁc marker
COL-19::GFPwas used (Thein et al., 2003). kaIs[col-19::gfp];adt-2(wk156)
was constructed by crossing COL-19::GFP males into adt-2(wk156) her-
maphrodites. The small hermaphrodites with COL-19::GFP reporter were
picked in the F2 generation. Plates bearing smalls and COL-19::GFP
reporter were selected and the cuticle was observed under the confocalmicroscope. kaIs[col-19::gfp];adt-2(tm975/wk156) was made by crossing
kaIs[col-19::gfp];adt-2(wk156) males into adt-2(tm975)/+ hermaphro-
dites. We also treated COL-19::GFP expressing worms on adt-2(RNAi).
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